BCLC Stage Calculator (Educational)
Use this tool to estimate a Barcelona Clinic Liver Cancer (BCLC) stage for hepatocellular carcinoma (HCC) based on common clinical inputs.
Important: This is a simplified educational calculator, not a medical diagnosis tool. Final staging and treatment planning should always be done by a hepatology/oncology team.
What Is a BCLC Calculator?
A BCLC calculator helps estimate the Barcelona Clinic Liver Cancer stage for patients with hepatocellular carcinoma (HCC). The BCLC system is widely used because it combines three major factors: tumor burden, liver function, and functional status. Unlike purely anatomical systems, BCLC staging also links each stage to common treatment pathways.
In clinical practice, staging is rarely based on one number alone. Doctors integrate imaging, blood work, liver reserve, symptoms, and patient goals. This calculator mirrors the core decision flow so you can understand how stage assignment typically works.
Inputs Used in This bclc calculator
ECOG Performance Status
ECOG describes how a person is functioning in daily life. Lower scores generally support curative or disease-controlling therapies, while higher scores may indicate the need for supportive care focus.
Child-Pugh Class
Child-Pugh class (A, B, C) estimates liver reserve. Since many HCC cases occur in cirrhosis, liver function can be just as important as tumor size. Poor liver reserve can move staging and treatment decisions toward less aggressive options.
Tumor Burden
Number of nodules and size of the largest lesion are used to separate very early/early disease from multinodular disease. A single very small lesion may fit BCLC 0, while larger or multiple lesions may fit BCLC A or BCLC B.
Vascular Invasion and Extrahepatic Spread
Macrovascular invasion or metastasis usually indicates advanced biology and often classifies as BCLC C if performance status and liver reserve allow active systemic treatment.
Simplified Staging Logic Used by This Tool
- BCLC D (Terminal): Child-Pugh C or ECOG 3-4.
- BCLC C (Advanced): Macrovascular invasion, extrahepatic spread, or ECOG 1-2.
- BCLC 0 (Very Early): ECOG 0, preserved liver function, one lesion ≤2 cm, no spread/invasion.
- BCLC A (Early): ECOG 0, no spread/invasion, single lesion up to 5 cm or up to 3 nodules each ≤3 cm.
- BCLC B (Intermediate): ECOG 0 with multinodular disease beyond BCLC A criteria, without spread/invasion.
How to Interpret Results
BCLC 0 (Very Early)
Usually associated with best long-term outcomes when curative treatment is feasible. Depending on portal pressure and bilirubin, resection or ablation may be considered.
BCLC A (Early)
Still potentially curable in selected patients. Common discussions include surgical resection, local ablation, and liver transplantation evaluation.
BCLC B (Intermediate)
Typically multinodular disease without invasion/metastasis and good function. Transarterial therapies such as TACE are commonly discussed, with individualized sequencing based on center expertise.
BCLC C (Advanced)
Usually includes vascular invasion, extrahepatic spread, or decreased performance status. Systemic therapy (often immunotherapy-based regimens) is frequently the central strategy if liver function allows.
BCLC D (Terminal)
At this stage, care often prioritizes symptom management, quality of life, and support for the patient and family. Palliative care plays a key role.
Why This Calculator Is Useful
- Helps patients and caregivers understand liver cancer staging terminology.
- Supports educational discussions before clinic visits.
- Shows how liver function and performance status influence treatment possibilities.
- Provides quick, transparent logic for stage estimation.
Limitations and Disclaimer
Real-world hepatocellular carcinoma management is more complex than any simple calculator. This tool does not include every modifier (e.g., AFP trends, detailed vascular anatomy, transplant eligibility rules, comorbidities, bleeding risk, local expertise, prior therapies, or molecular features). Use it for education and orientation only.
If you are making actual care decisions, consult a multidisciplinary team (hepatology, oncology, surgery, interventional radiology, and palliative specialists as needed).
Quick FAQ
Is BCLC the same as TNM?
No. TNM is anatomy-focused, while BCLC integrates liver function and performance status with treatment linkage.
Can BCLC stage change over time?
Yes. Stage can change after treatment response, disease progression, or shifts in liver reserve/functional status.
Should I use this result as a diagnosis?
No. Consider this a learning aid. Formal staging requires clinician review of complete clinical data.